Phase 3 Randomized Eortc 1325-Mg/Keynote-054 Study Results: Pembrolizumab Versus Placebo after Complete Resection in Patients with High-Risk Stage III Melanoma

A. Khattak, C. Robert, C. U. Blank, M. Mandala, G. V. Long, V. Atkinson, S. Dalle, A. Haydon, M. Lichinitser, M. S. Carlino, S. Sandhu, J. Larkin, S. Puig, P. A. Ascierto, P. Rutkowski, D. Schadendorf, P. Lorigan, N. Ibrahim, S. Suciu, A. M. M. Eggermont

    Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

    Original languageEnglish
    Pages (from-to)48-48
    Number of pages1
    JournalAsia-Pacific Journal of Clinical Oncology
    Publication statusPublished - Aug 2018

    Cite this